ChiCTR2200056036 版本V1.0 版本创建时间2022/09/18 18:10:26 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200056036 

最近更新日期:

Date of Last Refreshed on:

2022-01-31 01:40:06 

注册时间:

Date of Registration:

2022-01-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经皮穴位电刺激对行腹腔镜结直肠癌根治术的老年患者术后认知功能的影响

Public title:

Effects of transcutaneous electrical acupuncture stimulation for postoperative cognitive in elderly undergoing laparoscopic radical colorectal surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮穴位电刺激对行腹腔镜结直肠癌根治术的老年患者术后认知功能的影响

Scientific title:

Effects of transcutaneous electrical acupuncture stimulation for postoperative cognitive in elderly undergoing laparoscopic radical colorectal surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiMCTR2200005565

申请注册联系人:

姜婷婷 

研究负责人:

姜婷婷 

Applicant:

Jiang Tingting 

Study leader:

Jiang Tingting 

申请注册联系人电话:

Applicant telephone:

18131375043

研究负责人电话:

Study leader's telephone:

18131375043

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1247629186@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1247629186@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

河北省人民医院

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河北省石家庄市新华区和平西路348号

研究负责人通讯地址:

河北省石家庄市新华区和平西路348号

Applicant address:

348 Heping Road West, Xinhua District, Shijiazhuang, Hebei

Study leader's address:

348 Heping Road West, Xinhua District, Shijiazhuang, Hebei

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

河北省人民医院

Applicant's institution:

Hebei General Hospital

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2019)科研伦审第(48)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

河北省人民医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Hebei General Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2019-04-29 00:00:00

伦理委员会联系人:

鲁杨

Contact Name of the ethic committee:

Lu Yang

伦理委员会联系地址:

河北省石家庄市新华区和平西路348号

Contact Address of the ethic committee:

348 Heping Road West, Xinhua District, Shijiazhuang, Hebei

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

河北省人民医院

Primary sponsor:

Hebei General Hospital

研究实施负责(组长)单位地址:

河北省石家庄市新华区和平西路348号

Primary sponsor's address:

348 Heping Road West, Xinhua District, Shijiazhuang, Hebei

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北

市(区县):

石家庄

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

河北省人民医院

具体地址:

河北省石家庄市新华区和平西路348号

Institution
hospital:

Hebei General Hospital

Address:

348 Heping Road West, Xinhua District, Shijiazhuang, Hebei

经费或物资来源:

自筹

Source(s) of funding:

self-funded

Target disease:

Postoperative cognitive dysfunction

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探究经皮穴位电刺激对行腹腔镜结直肠癌根治术的老年患者术后认知功能的影响  

Objectives of Study:

To investigate the efficacy of TEAS on cognitive function in the elderly undergoing laparoscopic radical colorectal surgery

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄≥60岁(性别不限);
(2)在全身麻醉下行腹腔镜手术;
(3)BMI:18-30 kg/m2;
(4)ASA分级I-III级;
(5)同意接受本试验并签署知情同意书。

Inclusion criteria

(1) age ≥ 60 years (either gender);
(2) undergoing endotracheal intubation and laparoscopic radical colorectal surgery under general anesthesia;
(3) body mass index (BMI) 18-30 kg/m2;
(4) American Society of Anesthesiologists (ASA) classification levels I-III;
(5) patients provide signed informed consent.

排除标准:

(1)发生严重并发症;
(2)对电极片过敏;
(3)穴位刺激部位表面皮肤局部存在感染,伤口或瘢痕;
(4)患者有严重的中枢系统疾病及精神疾病;
(5)患者4周内参与其他临床试验;
(6)患者有听觉、视觉以及交流障碍。

Exclusion criteria:

(1) serious surgery complications;
(2) known allergy to a patch glue;
(3) patients with skin infections, surgical incision or scar at the point of application of acupuncture; (
4) preoperative complications involving severe CNS diseases or severe mental diseases;
(5) participated in other clinical trials within four weeks;
(6) patients with hearing, visual and communication impairments.

研究实施时间:

Study execute time:

From 2022-01-24 00:00:00 To 2022-06-24 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-01-24 00:00:00 To 2022-06-24 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

35

Group:

Experimental group

Sample size:

干预措施:

经皮穴位电刺激

干预措施代码:

Intervention:

Transcutaneous electrical acupuncture stimulation (TEAS)

Intervention code:

组别:

对照组

样本量:

35

Group:

Control group

Sample size:

干预措施:

常规全身麻醉

干预措施代码:

Intervention:

Conventional General Anesthesia

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北 

市(区县):

石家庄 

Country:

China 

Province:

Hebei 

City:

Shijiazhuang 

单位(医院):

河北省人民医院 

单位级别:

三级甲等 

Institution
hospital:

Hebei General Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

S100β 蛋白

指标类型:

主要指标

Outcome:

S100β protein

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

P物质

指标类型:

主要指标

Outcome:

Substance P

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

皮质醇

指标类型:

主要指标

Outcome:

cortisol

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究者使用随机数字表法分为两组

Randomization Procedure (please state who generates the random number sequence and by what method):

The researchers used a random number table to divide the two groups

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

于2023年6月以纸质方式公开,请阅读网页注册指南中关于 原始数据共享 的内容

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

It was released in paper form in June 2023

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

SPSS

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

SPSS

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-01-31 01:40:06